• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型垂体-性腺抑制剂17β-乙酰氧基-5α,17α-孕-2-烯-20-炔的药理学特性

Pharmacological profile of the new pituitary-gonadic suppressant 17 beta-acetoxy-5 alpha, 17 alpha-pregn-2-ene-20-yne.

作者信息

Paris J, Fournau P, Granero M, Lanquetin A, Thévenot R

出版信息

Arzneimittelforschung. 1986 Jul;36(7):1069-74.

PMID:3768074
Abstract

17 beta-Acetoxy-5 alpha, 17 alpha-pregn-2-ene-20-yne (TX 380) strongly suppresses the hypophyso-gonadic axis at central and peripheral levels. Depending on the dosage and on the hormonal status at the time of treatment, this combined inhibition results in major disturbances of the estrus cycle and in impaired ovulation. TX 380 shows minimal androgenic activity. It exerts no effect on the fetal female urogenital tract during gestation. TX 380 possesses only weak estrogenic properties, and does not promote endometrial proliferation in the female rabbit. Moreover, it markedly opposes the action of progesterone. Given this pharmacological profile, TX 380 stands as a candidate drug in the treatment of gynecologic affections, such as endometriosis and benign breast disease, and as a potential contraceptive agent.

摘要

17β-乙酰氧基-5α,17α-孕甾-2-烯-20-炔(TX 380)在中枢和外周水平强烈抑制垂体-性腺轴。根据治疗时的剂量和激素状态,这种联合抑制会导致发情周期的重大紊乱和排卵受损。TX 380的雄激素活性极小。在妊娠期,它对雌性胎儿泌尿生殖道无影响。TX 380仅具有微弱的雌激素特性,且不会促进雌性兔子宫内膜增殖。此外,它明显拮抗孕酮的作用。鉴于这种药理学特性,TX 380可作为治疗子宫内膜异位症和良性乳腺疾病等妇科疾病的候选药物,以及作为一种潜在的避孕药。

相似文献

1
Pharmacological profile of the new pituitary-gonadic suppressant 17 beta-acetoxy-5 alpha, 17 alpha-pregn-2-ene-20-yne.新型垂体-性腺抑制剂17β-乙酰氧基-5α,17α-孕-2-烯-20-炔的药理学特性
Arzneimittelforschung. 1986 Jul;36(7):1069-74.
2
The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative.新型口服孕激素TX 066(17α-乙酰氧基-6-甲基-19-去甲-4,6-孕二烯-3,20-二酮)的药理学特征
Arzneimittelforschung. 1983;33(5):710-5.
3
Irreversible effects of neonatal exposure to p-tert-octylphenol on the reproductive tract in female rats.新生大鼠暴露于对叔辛基苯酚对其雌性生殖道的不可逆影响。
Toxicol Appl Pharmacol. 2000 Jun 15;165(3):217-26. doi: 10.1006/taap.2000.8940.
4
[Endocrinologic action spectrum of 19-nor-17-alpha-hydroxyprogesterone capronate (Gestonorone capronate)].19-去甲-17α-羟基己酸孕酮(己酸孕诺酮)的内分泌作用谱
Arzneimittelforschung. 1968 Oct;18(10):1289-97.
5
[Animal experiment studies on the central and peripheral effectiveness of clomiphene dihydrogencitrate].
Z Geburtshilfe Gynakol. 1971;174(1):35-58.
6
[Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].在首款口服避孕药问世30年后,对一种新型雌激素-孕激素复方制剂(一种含孕二烯酮的三相片)进行临床和生物学分析。
Fertil Contracept Sex. 1988 Apr;16(4 Suppl):1-8.
7
[The effect of ethymizole on the gonadotropic function of the hypophysis].[乙嘧唑对垂体促性腺功能的影响]
Farmakol Toksikol. 1972 Sep-Oct;35(5):563-6.
8
[Antifertility effect of 17 beta-hydroxy-7 alpha-methylandrost-5-en-3-one and its hormonal activity (author's transl)].
Yao Xue Xue Bao. 1981 Jan;16(1):8-13.
9
Further report on the endocrinological profile of 17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9(10)-diene-3-one (STS 557) in rodents.关于17α-氰甲基-17β-羟基-雌甾-4,9(10)-二烯-3-酮(STS 557)在啮齿动物体内内分泌特征的进一步报告。
Endokrinologie. 1982 Jun;79(2):173-84.
10
[The effect of an ovulation inhibitor (17-alpha-ethinyl-19-nortestosterone) on gonadotropic cells of the rat hypophysis].
Beitr Pathol Anat. 1965 Jul;132(1):1-24.